Optase Dry Eye Intense Drops (Glycerin 0.2%) recall
FDA recall D-0499-2026 · initiated Apr 20, 2026
SCOPE HEALTH recalled Optase Dry Eye Intense Drops (Glycerin 0.2%) in Apr 2026 — an FDA Class II recall (D-0499-2026) because Lack of Assurance of Sterility.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Lack of Assurance of Sterility
Sterility could not be assured
The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Details
- Product
- Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.
- Recalling company
- SCOPE HEALTH
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide within the United States
- Initiated
- Apr 20, 2026
- FDA report date
- May 6, 2026
Frequently asked
- Was Optase Dry Eye Intense Drops (Glycerin 0.2%) recalled?
- SCOPE HEALTH recalled Optase Dry Eye Intense Drops (Glycerin 0.2%) in Apr 2026 — an FDA Class II recall (D-0499-2026) because Lack of Assurance of Sterility. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Optase Dry Eye Intense Drops (Glycerin 0.2%) recalled?
- Per the FDA enforcement record, the reason for recall D-0499-2026 was: Lack of Assurance of Sterility
- Is a recalled Optase Dry Eye Intense Drops (Glycerin 0.2%) dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Optase Dry Eye Intense Drops (Glycerin 0.2%) are affected?
- Distributed: Nationwide within the United States. The recall covers these lots — Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0499-2026.